• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    HCSG Reports Second Quarter Results

    7/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care
    Get the next $HCSG alert in real time by email

    Exceeds Growth Expectations

    Raises 2025 Cash Flow Forecast

    Announces $50.0MM Share Repurchase Plan

    • Revenue of $458.5 million, an increase of 7.6% over the prior year.
    • Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring.
    • Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year.
    • Reiterates 2025 mid-single digit growth expectations.
    • Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to $85.0 million.
    • Announces $50.0 million, 12-month share repurchase plan.

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended June 30, 2025.

    Ted Wahl, Chief Executive Officer, stated, "Second quarter growth exceeded our expectations. New client wins and higher retention drove our organic growth, and we have carried that positive momentum into the back half of the year. Despite the previously announced Genesis news and resulting impact on our Q2 reported results, our 2025 growth plans and cash flow outlook remain strong. We are confident that continuing to execute on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, while delivering sustainable, profitable results."

    Second Quarter Results

    • Revenue was reported at $458.5 million. Segment revenues for Environmental and Dietary Services were reported at $205.8 million and $252.7 million, respectively.
      • The Company reiterated its expectation for 2025 mid-single digit revenue growth.
    • Cost of services was reported at $455.5 million or 99.4% and includes the impact of the $61.2 million or 13.4% non-cash charge related to the previously announced Genesis restructuring.
      • The Company's goal is to manage the second half of 2025 cost of services in the 86% range.
    • SG&A was reported at $49.2 million; after adjusting for the $4.7 million increase in deferred compensation, actual SG&A was $44.5 million or 9.7%.
      • The Company expects to manage SG&A in the 9.5% to 10.5% range in the near term, with the longer term goal of managing those costs into the 8.5% to 9.5% range.
    • Segment margin for Environmental Services was reported at 0.8% and includes the impact of a $20.3 million or 9.9% non-cash charge related to the previously announced Genesis restructuring. Segment margin for Dietary Services was reported at (10.1%), and includes the impact of a $40.9 million or 16.2% non-cash charge related to the previously announced Genesis restructuring.
    • Net income and diluted EPS were reported at ($32.4) million and ($0.44), respectively, and includes the impact of the $0.65 non-cash charge (or $61.2 million pretax, tax effected at 22.7%) related to the previously announced Genesis restructuring.
      • As previously announced, the Company estimates a third quarter $0.04 per share non-cash charge related to the Genesis restructuring.
    • Cash flow from operations was reported at $28.8 million; after adjusting for the $20.3 million increase in the payroll accrual, cash flow from operations was $8.5 million.
      • The Company raised its 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to $85.0 million.

    Balance Sheet and Liquidity

    The Company's primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. As of the end of the second quarter, the Company had cash and marketable securities of $164.1 million and a $500.0 million credit facility, inclusive of its $200.0 million accordion, which expires in November 2027.

    Share Repurchases

    The Company also announced that it plans to accelerate the pace of its share buybacks, and over the next 12 months, intends to repurchase $50.0 million shares of its common stock under its February 2023 share repurchase authorization. The Company repurchased $7.6 million of common stock during the second quarter. Year to date, the Company has repurchased $14.6 million of its common stock.

    Mr. Wahl stated, "Over the course of the last several years, we have continuously strengthened our balance sheet and expect strong cash flow generation over the next 12 months and beyond. We have demonstrated a prudent and balanced approach to capital allocation, including first and foremost investing in our growth initiatives. The current valuation of our stock relative to our long-term growth potential offers a unique opportunity with the buyback to return significant capital to shareholders."

    Conference Call and Upcoming Events

    The Company will host a conference call on Wednesday, July 23, 2025, at 8:30 a.m. Eastern Time to discuss its results for the three months ended June 30, 2025. The call may be accessed via phone at 1 (800) 715-9871, Conference ID: 9951274. The call will be simultaneously webcast under the "Events & Presentations" section of the Investor Relations page on the Company's website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

    The Company will be attending and presenting at the Baird 2025 Global Healthcare Conference on September 10, 2025 at the InterContinental Barclay NY.

    About Healthcare Services Group, Inc.

    Healthcare Services Group (NASDAQ:HCSG) is a leader in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. With nearly 50 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for our clients.

    CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

    This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as "believes," "anticipates," "plans," "expects," "estimates," "will," "goal," "intend" and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers' compensation, general liability and auto insurance; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company's expectations with respect to selling, general, and administrative expense; the impacts of past or future cyber attacks or breaches; global events including ongoing international conflicts; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2024 under "Government Regulation of Customers," "Service Agreements and Collections," and "Competition" and under Item 1A. "Risk Factors" in such Form 10-K.

    These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.

    In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

    USE OF NON-GAAP FINANCIAL INFORMATION

    To supplement HCSG's consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

    The Company is presenting net cash flow from operations (excluding the impact of payroll accrual), earnings before interest, taxes, depreciation and amortization ("EBITDA") and EBITDA excluding items impacting comparability ("Adjusted EBITDA"). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

     
     
     

    HEALTHCARE SERVICES GROUP, INC.

    CONSOLIDATED STATEMENTS OF (LOSS) INCOME

    (Unaudited)

    (in thousands, except per share data)
     

     

     

    For the Three Months Ended

     

    For the Six Months Ended

     

    June 30,

     

    June 30,

     

    2025

     

    2024

     

    2025

     

    2024

    Revenue

    $

    458,491

     

     

    $

    426,288

     

     

    $

    906,153

     

     

    $

    849,721

    Operating costs and expenses:

     

     

     

     

     

     

     

    Cost of services

     

    455,533

     

     

     

    384,742

     

     

     

    835,224

     

     

     

    743,653

     

    Selling, general and administrative

     

    49,163

     

     

     

    44,437

     

     

     

    94,129

     

     

     

    91,348

     

    (Loss) income from operations

     

    (46,205

    )

     

     

    (2,891

    )

     

     

    (23,200

    )

     

     

    14,720

     

    Other income, net

     

    4,317

     

     

     

    905

     

     

     

    5,206

     

     

     

    4,608

     

    (Loss) income before income taxes

     

    (41,888

    )

     

     

    (1,986

    )

     

     

    (17,994

    )

     

     

    19,328

     

     

     

     

     

     

     

     

     

    Income tax (benefit) provision

     

    (9,522

    )

     

     

    (198

    )

     

     

    (2,856

    )

     

     

    5,807

     

    Net (loss) income

    $

    (32,366

    )

     

    $

    (1,788

    )

     

    $

    (15,138

    )

     

    $

    13,521

     

     

     

     

     

     

     

     

     

    Basic (loss) income per share

    $

    (0.44

    )

     

    $

    (0.02

    )

     

    $

    (0.21

    )

     

    $

    0.18

     

     

     

     

     

     

     

     

     

    Diluted (loss) income per common share

    $

    (0.44

    )

     

    $

    (0.02

    )

     

    $

    (0.21

    )

     

    $

    0.18

     

     

     

     

     

     

     

     

     

    Basic weighted average number of common shares outstanding

     

    73,161

     

     

     

    73,853

     

     

     

    73,414

     

     

     

    73,889

     

     

     

     

     

     

     

     

     

    Diluted weighted average number of common shares outstanding

     

    73,161

     

     

     

    73,853

     

     

     

    73,414

     

     

     

    74,048

     

     
     
     
     

    HEALTHCARE SERVICES GROUP, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

    (in thousands)
     

     

     

    June 30, 2025

     

    December 31, 2024

    Cash and cash equivalents

    $

    82,818

     

    $

    56,776

    Restricted cash equivalents

     

    326

     

     

     

    3,355

     

    Marketable securities, at fair value

     

    51,674

     

     

     

    50,535

     

    Restricted marketable securities, at fair value

     

    29,258

     

     

     

    25,105

     

    Accounts receivable, net

     

    292,210

     

     

     

    330,907

     

    Notes receivable — short-term, net

     

    31,628

     

     

     

    51,429

     

    Other current assets

     

    44,380

     

     

     

    38,545

     

    Total current assets

     

    532,294

     

     

     

    556,652

     

     

     

     

     

    Property and equipment, net

     

    28,215

     

     

     

    28,198

     

    Notes receivable — long-term, net

     

    45,084

     

     

     

    41,054

     

    Goodwill

     

    80,042

     

     

     

    75,529

     

    Other intangible assets, net

     

    8,263

     

     

     

    9,442

     

    Deferred compensation funding

     

    51,548

     

     

     

    49,639

     

    Other assets

     

    56,754

     

     

     

    42,258

     

    Total assets

    $

    802,200

     

     

    $

    802,772

     

     

     

     

     

    Accrued insurance claims — current

    $

    24,578

     

     

    $

    25,148

     

    Other current liabilities

     

    189,354

     

     

     

    167,399

     

    Total current liabilities

     

    213,932

     

     

     

    192,547

     

     

     

     

     

    Accrued insurance claims — long-term

     

    50,833

     

     

     

    51,869

     

    Deferred compensation liability — long-term

     

    51,699

     

     

     

    50,011

     

    Lease liability — long-term

     

    7,048

     

     

     

    8,033

     

    Other long-term liabilities

     

    1,650

     

     

     

    385

     

     

     

     

     

    Stockholders' equity

     

    477,038

     

     

     

    499,927

     

    Total liabilities and stockholders' equity

    $

    802,200

     

     

    $

    802,772

     

     
     
     
     

    HEALTHCARE SERVICES GROUP, INC.

    RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

    (Unaudited)
     

     

    Reconciliation of GAAP net (loss) income to EBITDA and adjusted EBITDA (in thousands)

     

    For the Three Months Ended

     

    For the Six Months Ended

     

    June 30,

     

    June 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    GAAP net (loss) income

     

    $

    (32,366

    )

     

    $

    (1,788

    )

     

    $

    (15,138

    )

     

    $

    13,521

     

    Income tax (benefit) provision

     

     

    (9,522

    )

     

     

    (198

    )

     

     

    (2,856

    )

     

     

    5,807

     

    Interest, net

     

     

    (1,976

    )

     

     

    184

     

     

     

    (4,186

    )

     

     

    138

     

    Depreciation and amortization(1)

     

     

    5,001

     

     

     

    3,679

     

     

     

    8,879

     

     

     

    7,210

     

    EBITDA

     

    $

    (38,863

    )

     

    $

    1,877

     

     

    $

    (13,301

    )

     

    $

    26,676

     

    Share-based compensation

     

     

    2,541

     

     

     

    2,113

     

     

     

    6,279

     

     

     

    4,597

     

    Adjusted EBITDA

     

    $

    (36,322

    )

     

    $

    3,990

     

     

    $

    (7,022

    )

     

    $

    31,273

     

    Adjusted EBITDA as a percentage of revenue

     

     

    (7.9

    )%

     

     

    0.9

    %

     

     

    (0.8

    )%

     

     

    3.7

    %

    Reconciliation of GAAP cash flows provided by (used in) operations to net cash flows from operations (excluding the change in payroll accrual)

     

    For the Three Months Ended

     

    For the Six Months Ended

     

    June 30,

     

    June 30,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    GAAP cash flows provided by (used in) operations

     

    $

    28,787

     

     

    $

    16,319

     

     

    $

    56,288

     

     

    $

    (9,714

    )

    Accrued payroll(2)

     

     

    (20,256

    )

     

     

    (18,677

    )

     

     

    (15,665

    )

     

     

    (1,862

    )

    Cash flows from operations (excluding the change in payroll accrual)

     

    $

    8,531

     

     

    $

    (2,358

    )

     

    $

    40,623

     

     

    $

    (11,576

    )

    1.

    Includes right-of-use asset depreciation of $2.1 million and $4.2 million for the three and six months ended June 30, 2025, and $1.9 million and $3.8 million for the three and six months ended June 30, 2024.

    2.

    The accrued payroll adjustment reflects changes in accrued payroll for the three and six months ended June 30, 2025 and 2024. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company's quarterly cash flow performance.

     
     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250723023712/en/

    Company Contacts:

    Theodore Wahl

    President and Chief Executive Officer

    Vikas Singh

    Executive Vice President and Chief Financial Officer

    Matthew J. McKee

    Chief Communications Officer

    215-639-4274

    [email protected]

    Get the next $HCSG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCSG

    DatePrice TargetRatingAnalyst
    7/29/2025$16.00Neutral → Outperform
    Macquarie
    4/24/2025$15.00Neutral → Buy
    UBS
    12/16/2024Neutral
    Macquarie
    3/24/2023$8.50 → $14.00Underperform → Hold
    Jefferies
    2/17/2023$14.00 → $17.00Sector Perform → Outperform
    RBC Capital Mkts
    10/20/2022$18.00Hold → Buy
    The Benchmark Company
    2/10/2022$19.00 → $13.50Hold → Underperform
    Jefferies
    10/22/2021$28.00 → $22.00Neutral
    Credit Suisse
    More analyst ratings

    $HCSG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simmons Kurt Jr was granted 892 shares, increasing direct ownership by 3% to 26,596 units (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    10/2/25 4:09:36 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Director Whalen Thomas Gerard was granted 149 shares, increasing direct ownership by 5% to 3,020 units (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    10/2/25 4:07:50 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    EVP & Chief Admin. Officer Shea John Christopher sold $283,126 worth of shares (21,368 units at $13.25), decreasing direct ownership by 39% to 32,976 units (SEC Form 4)

    4 - HEALTHCARE SERVICES GROUP INC (0000731012) (Issuer)

    7/30/25 4:20:05 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Healthcare Services Group upgraded by Macquarie with a new price target

    Macquarie upgraded Healthcare Services Group from Neutral to Outperform and set a new price target of $16.00

    7/29/25 10:30:39 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group upgraded by UBS with a new price target

    UBS upgraded Healthcare Services Group from Neutral to Buy and set a new price target of $15.00

    4/24/25 7:18:16 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Macquarie initiated coverage on Healthcare Services Group

    Macquarie initiated coverage of Healthcare Services Group with a rating of Neutral

    12/16/24 7:46:05 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HCSG Reports Second Quarter Results

    Exceeds Growth Expectations Raises 2025 Cash Flow Forecast Announces $50.0MM Share Repurchase Plan Revenue of $458.5 million, an increase of 7.6% over the prior year. Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring. Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to

    7/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Provides Update On Client Restructuring, Reiterates 2025 Growth and Cash Flow Expectations

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today issued the following statement related to the Genesis HealthCare, Inc. ("Genesis") announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Texas on July 9, 2025 (the "Petition Date"). HCSG currently provides services to 164 Genesis facilities. Following the Petition Date, HCSG expects to continue its contractual relationship with those Genesis facilities without disruption in service or payments. As of the Petition Date, the estimated accounts and notes receivable balances of Genesis, net of reserves, were $50.0 million and $14.4 million, respectively. As a result of the Genesis filing, HCSG estima

    7/10/25 1:07:00 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports First Quarter Results

    Delivers Strong Revenue, Earnings & Cash Flow Revenue of $447.7 million, an increase of 5.7% over the prior year. Net income and diluted EPS of $17.2 million and $0.23. Reported cash flow from operations of $27.5 million; cash flow from operations (excluding the change in payroll accrual) of $32.1 million, an increase of $41.3 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $45.0 to $60.0 million to $60.0 to $75.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended March 31, 2025. Ted Wahl, Chief Ex

    4/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    SEC Filings

    View All

    SEC Form 10-Q filed by Healthcare Services Group Inc.

    10-Q - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    7/25/25 4:03:10 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    7/23/25 7:10:38 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Healthcare Services Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - HEALTHCARE SERVICES GROUP INC (0000731012) (Filer)

    7/10/25 2:49:55 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Healthcare Services Group Inc.

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    11/13/24 5:15:34 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Healthcare Services Group Inc.

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    10/15/24 1:08:04 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Healthcare Services Group Inc. (Amendment)

    SC 13G/A - HEALTHCARE SERVICES GROUP INC (0000731012) (Subject)

    2/13/24 5:06:23 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Financials

    Live finance-specific insights

    View All

    HCSG Reports Second Quarter Results

    Exceeds Growth Expectations Raises 2025 Cash Flow Forecast Announces $50.0MM Share Repurchase Plan Revenue of $458.5 million, an increase of 7.6% over the prior year. Net income and diluted EPS of ($32.4) million and ($0.44); includes $0.65 non-cash charge related to previously announced Genesis HealthCare restructuring. Cash flow from operations of $28.8 million; cash flow from operations (excluding the change in payroll accrual) of $8.5 million, an increase of $10.9 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $60.0 to $75.0 million to $70.0 to

    7/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Provides Update On Client Restructuring, Reiterates 2025 Growth and Cash Flow Expectations

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today issued the following statement related to the Genesis HealthCare, Inc. ("Genesis") announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Texas on July 9, 2025 (the "Petition Date"). HCSG currently provides services to 164 Genesis facilities. Following the Petition Date, HCSG expects to continue its contractual relationship with those Genesis facilities without disruption in service or payments. As of the Petition Date, the estimated accounts and notes receivable balances of Genesis, net of reserves, were $50.0 million and $14.4 million, respectively. As a result of the Genesis filing, HCSG estima

    7/10/25 1:07:00 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    HCSG Reports First Quarter Results

    Delivers Strong Revenue, Earnings & Cash Flow Revenue of $447.7 million, an increase of 5.7% over the prior year. Net income and diluted EPS of $17.2 million and $0.23. Reported cash flow from operations of $27.5 million; cash flow from operations (excluding the change in payroll accrual) of $32.1 million, an increase of $41.3 million over the prior year. Reiterates 2025 mid-single digit growth expectations. Raises 2025 cash flow from operations forecast (excluding the change in payroll accrual) from $45.0 to $60.0 million to $60.0 to $75.0 million. Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended March 31, 2025. Ted Wahl, Chief Ex

    4/23/25 7:00:00 AM ET
    $HCSG
    Hospital/Nursing Management
    Health Care

    $HCSG
    Leadership Updates

    Live Leadership Updates

    View All

    HCSG Announces Appointment of Chief Financial Officer

    Healthcare Services Group, Inc. (NASDAQ:HCSG) today announced the appointment of Vikas Singh as EVP & Chief Financial Officer, effective September 3, 2024. He will oversee HCSG's accounting and finance operations, and play a key role in corporate development, investor relations, and the success of its long-term growth strategy. Mr. Singh brings over two decades of diverse experience in finance, strategy and operations to the Company. Most recently, he served as Managing Director of Leveraged Finance & Capital Markets at Bank of America Securities. Prior to that he worked in the Financial Sponsors Group at Credit Suisse and in the Asia-Pacific Credit Card Group at Citibank. Mr. Singh began

    9/9/24 12:00:00 PM ET
    $HCSG
    Hospital/Nursing Management
    Health Care